Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

28 29 Next >

Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move ↗

August 12, 2024

There isn't much to suggest these businesses are actually vulnerable.

Via The Motley Fool

Here's Why Eli Lilly Stock Dropped 12% Last Month ↗

August 08, 2024

News from a competitor gave investors an unwelcome dose of reality.

Via The Motley Fool

$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today ↗

August 05, 2024

Via Benzinga

3 Unstoppable Stocks to Buy in August ↗

August 03, 2024

It's not hard to envision how all three of these stocks can deliver exceptional growth.

Via The Motley Fool

Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now. ↗

August 02, 2024

Via The Motley Fool

Viking Therapeutics's Options: A Look at What the Big Money is Thinking ↗

July 26, 2024

Via Benzinga

What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks. ↗

August 01, 2024

Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks.

Via InvestorPlace

8 Health Care Stocks With Whale Alerts In Today's Session ↗

August 01, 2024

Via Benzinga

Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening ↗

August 01, 2024

Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2024

Via Benzinga

Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma ↗

July 30, 2024

Both companies have a clear path to competing successfully in the market.

Via The Motley Fool

3 Overlooked Stocks Poised for a Breakout Very Soon ↗

July 29, 2024

Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio.

Via InvestorPlace

Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. ↗

July 29, 2024

The Federal Reserve's fight against inflation may soon yield financial benefits.

Via The Motley Fool

Topics Economy

The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It. ↗

July 29, 2024

One preliminary piece of evidence is sending its shares higher.

Via The Motley Fool

Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia. ↗

July 29, 2024

Should you get in on this stock now?

Via The Motley Fool

ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗

July 28, 2024

Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%

Via Benzinga

Is Viking Therapeutics a Millionaire-Maker Stock? ↗

July 27, 2024

The stock rose 120% in one trading session earlier this year on positive clinical trial news.

Via The Motley Fool

Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review ↗

July 26, 2024

Small caps continued to lead, while the Nasdaq broke below key levels.

Via Investor's Business Daily

Why Weight Loss Drug Developer Stocks Tumbled on Thursday ↗

July 25, 2024

Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.

Via The Motley Fool

Novo Nordisk Shares Decline Amid Competitive Pressure ↗

July 25, 2024

Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).

Via Benzinga

Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings ↗

July 25, 2024

Via Benzinga

Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 25, 2024

Via Benzinga

Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know ↗

July 25, 2024

Viking Therapeutics Inc (NASDAQ:VKTX) shares are rising Thursday after the biotech company announced plans to advance its experimental weight loss drug to late-stage trials.

Via Benzinga

Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast ↗

July 25, 2024

Via Benzinga

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday ↗

July 25, 2024

Via Benzinga

Why Eli Lilly and Company Shares Are Moving Lower On Thursday ↗

July 25, 2024

Eli Lilly and Company stock is trading lower on Thursday after Viking Therapeutics announced the advancement of its novel treatment for obesity, VK2735.

Via Benzinga

Viking Therapeutics: Pharma Stock Soars on Positive Earnings

July 25, 2024

Viking Therapeutics stock soars on clinical trial results and a solid earnings beat, signaling a potential market shake-up in the biopharmaceutical sector.

Via MarketBeat

Topics Earnings

Why Viking Therapeutics Stock Is Skyrocketing Today ↗

July 25, 2024

The clinical-stage biopharmaceutical company should soon be closer to potentially launching its first product.

Via The Motley Fool

CON Stock: 7 Things to Know as Concentra Group Starts Trading Today ↗

July 25, 2024

Concentra Group stock is a hot topic on Thursday as investors prepare for CON stock to start trading with its IPO today.

Via InvestorPlace

Topics Initial Public Offering

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk ↗

July 25, 2024

Viking Therapeutics stock rocketed Thursday after the company said it's exploring a monthly dose of its weight-loss drug.

Via Investor's Business Daily

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today